Breast Cancer, Stage IA (DBCOND0164320)

Identifiers

Synonyms
Stage IA Breast Cancer

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06268665
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyNo drug interventionstreatment2recruiting
NCT01805076
MRI and Mammography Before Surgery in Patients With Stage I-II Breast CancerNo drug interventionsdiagnostic3active_not_recruiting
NCT01723943
Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT02370264
Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast CancerNo drug interventionssupportive_careNot Availableterminated
NCT01869764
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancertreatment2completed
NCT01672684
Phase I: At-Home Support for Rural Women Using Group Video CallingNo drug interventionssupportive_care1completed
NCT01941784
Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT00450879
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgerytreatment1terminated
NCT01372579
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patientstreatment2unknown_status
NCT02168179
KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT02002533
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT01819233
Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT01276054
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.supportive_care2terminated
NCT02235051
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer SurvivorsNo drug interventionspreventionNot Availablecompleted
NCT02454777
High-Intensity Interval Training for Stage I-III Breast Cancer PatientsNo drug interventionssupportive_careNot Availableterminated
NCT01106898
Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgerytreatment2completed
NCT01791998
Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast CancerNo drug interventionstreatmentNot Availablewithdrawn
NCT01570998
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumorstreatment1terminated
NCT02699983
eHealth Weight Loss Program in African American Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT01292083
Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By SurgerytreatmentNot Availablewithdrawn
NCT02314156
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomyprevention2completed
NCT01729832
Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT03091842
Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT01824836
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)supportive_careNot Availableactive_not_recruiting
NCT03128619
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancertreatment1terminated
NCT03139435
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT03050463
Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01928186
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerdiagnosticNot Availablecompleted
NCT03198286
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer SurvivorsNo drug interventionshealth_services_researchNot Availablecompleted
NCT01319539
MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast CancerNo drug interventionstreatment2terminated
NCT02702830
MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT01881048
Window of Opportunity Study Targeting the Inflammatory Milieutreatment0active_not_recruiting
NCT03345420
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast CancerNo drug interventionstreatment2active_not_recruiting
NCT01522820
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumorstreatment1completed
NCT01750073
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancertreatment2active_not_recruiting
NCT01982591
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00513292
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgerytreatment3completed
NCT03039140
Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT03284346
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availableterminated
NCT02927912
Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With ReconstructionNo drug interventionstreatment2recruiting
NCT03233555
Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02566408
Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical ActivityNo drug interventionssupportive_careNot Availablecompleted
NCT01753908
Broccoli Sprout Extract in Treating Patients With Breast CancerNo drug interventionsbasic_science0completed
NCT03238703
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancertreatment4withdrawn
NCT00066690
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancertreatment3active_not_recruiting
NCT00194779
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgerytreatment2completed
NCT02415387
Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancerbasic_science0completed
NCT01222377
Endoscopic Breast Surgery in Treating Patients With Breast CancerNo drug interventionstreatmentNot Availableterminated
NCT01478477
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or LetrozoleNo drug interventionspreventionNot Availablecompleted
NCT02526498
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After SurgeryNo drug interventionstreatment2completed
NCT01409811
Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic AcidtreatmentNot Availableterminated
NCT00407888
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgerytreatment2completed
NCT01712815
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast CancerNo drug interventionsdiagnosticNot Availableterminated
NCT02203552
Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancerprevention2unknown_status
NCT01219075
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast CancerNo drug interventionspreventionNot Availablecompleted
NCT03061175
Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic MastectomyNo drug interventionssupportive_careNot Availablecompleted
NCT02186470
Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01243541
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving PaclitaxelNo drug interventionssupportive_careNot Availableterminated
NCT01483196
Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT02728596
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)No drug interventionshealth_services_researchNot Availablecompleted
NCT02662335
Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT02587663
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRINo drug interventionsdiagnosticNot Availablecompleted
NCT03025139
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)No drug interventionssupportive_careNot Availableunknown_status
NCT01800422
Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancertreatment2unknown_status
NCT02760030
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgerytreatment2recruiting
NCT00618657
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Settingtreatment2completed
NCT05318274
Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.No drug interventionstreatmentNot Availablerecruiting
NCT02400060
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT02677389
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in WisconsinNo drug interventionssupportive_careNot Availablecompleted
NCT01391689
Diindolylmethane in Treating Patients With Breast CancerNo drug interventionstreatmentNot Availablecompleted
NCT02432950
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01849250
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivorsprevention2completed
NCT02023008
Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation TherapyNo drug interventionssupportive_careNot Availableterminated
NCT02414646
Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancertreatment2active_not_recruiting